Merck Canada

Merck Canada is the Canadian subsidiary of Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the US and Canada). The company is a leading research-intensive biopharmaceutical firm focused on delivering innovative health solutions through a broad portfolio of prescription medicines, vaccines, and animal health products. Its primary therapeutic areas include oncology, where it markets the blockbuster immunotherapy Keytruda, as well as infectious diseases, vaccines, and cardiometabolic disorders. Headquartered in Kirkland, Quebec, Merck Canada plays a significant role in the Canadian life sciences ecosystem through clinical trials and local investments. The company is distinct from the German Merck KGaA, which operates in Canada as EMD Serono.